Skip to main content
Premium Trial:

Request an Annual Quote

ABI Partners with Geospiza, GenomeQuest to Build Bioinformatics Platform for Next-Gen Sequencing

NEW YORK (GenomeWeb News) - Applied Biosystems said today that it has signed formal agreements with Geospiza and GenomeQuest in an effort to develop bioinformatics tools for analyzing and managing data generated by its SOLiD next-generation sequencing system.
 
Under the terms of the agreement with Geospiza, ABI expanded an existing relationship with the firm to ensure that Geospiza’s Finch software, originally designed to automate sequencing workflows for capillary electrophoresis systems, will support the SOLiD system.
 
The agreement with GenomeQuest will ensure that the company’s sequence search platform is integrated with the SOLiD platform.
 
ABI said that it has shared file formats, sample data sets, and analysis pipeline information with both firms so that they can “configure their products, services and capabilities to address customer challenges associated with generating, analyzing, and managing research data in key applications for the SOLiD System.” 
 
The company noted that the SOLiD can generate more than 4 gigabases of sequence data in a single run — far more than the 3 billion bases that comprise the human genome. ABI said that it has partnered with Geospiza and GenomeQuest “to help address managing this vast amount of genomic data by providing complementary services, including the IT infrastructure to manage the data, as well as the ability to process the data and align it to a reference sequence.” 
 
The agreements grew out of ABI’s Software Development Community, which the company originally launched in 2006 to foster third-party software development around its instrumentation platforms. The company expanded the community in 2007 to focus on the challenges of analyzing and managing data generated by next-generation sequencers.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.